Pia Kvistborg

17.8k citations

50 papers · 3.1k indexed · 2 hit papers · h-index 22

Oncology top 1%
Immunology top 1%
Molecular Biology top 10%
Pulmonary and Respiratory Medicine top 10%
Cancer Research top 10%

Co-authors: Ton N. Schumacher Wouter Scheper John B.A.G. Haanen Bianca Heemskerk Daisy Philips Sander Kelderman Marit M. van Buuren Mireille Toebes
Topics: Immunotherapy and Immune Responses (36 papers)Cancer Immunotherapy and Biomarkers (27 papers)CAR-T cell therapy research (21 papers)
Cited by: Immunology Oncology Cancer Research
Journals: Proceedings of the National Academy of Sciences Nature Communications Journal of Clinical Oncology
Partner nations: Netherlands United States Denmark

In The Last Decade

Pia Kvistborg

49 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma

2013 624 citations Daisy Philips, Mireille Toebes et al. Journal of Clinical Oncology profile →
Cancer Neoantigens

2018 400 citations Ton N. Schumacher, Pia Kvistborg et al. profile →

Peers

Countries citing papers authored by Pia Kvistborg

Since Specialization

Citations

This map shows the geographic impact of Pia Kvistborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pia Kvistborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pia Kvistborg more than expected).

Fields of papers citing papers by Pia Kvistborg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pia Kvistborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pia Kvistborg. The network helps show where Pia Kvistborg may publish in the future.

Co-authorship network of co-authors of Pia Kvistborg

This figure shows the co-authorship network connecting the top 25 collaborators of Pia Kvistborg. A scholar is included among the top collaborators of Pia Kvistborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pia Kvistborg. Pia Kvistborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy 2024 ·Frontiers in Immunology ·Anastasia Gangaev,Yannick van Sleen,(unknown),(unknown),(unknown),(unknown),Annemarie Boerma,Marieke van der Heiden,Sjoukje F. Oosting,Astrid A.M. van der Veldt,T. Jeroen N. Hiltermann,Corine H. GeurtsvanKessel,Anne‐Marie C. Dingemans,Egbert F. Smit,Elisabeth G.E. de Vries,John B.A.G. Haanen,Pia Kvistborg,Debbie van Baarle	2
2	Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response 2021 ·Proceedings of the National Academy of Sciences ·Anastasia Gangaev,Elisa A. Rozeman,Maartje W. Rohaan,Olga I. Isaeva,Daisy Philips,(unknown),Joost H. van den Berg,Antoni Ribas,Dirk Schadendorf,Bastian Schilling,Ton N. Schumacher,Christian U. Blank,John B.A.G. Haanen,Pia Kvistborg	21
3	Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features 2021 ·Nature Communications ·Anastasia Gangaev,Steven L. C. Ketelaars,Olga I. Isaeva,(unknown),(unknown),(unknown),Sara De Biasi,Lara Gibellini,Cristina Mussini,Giovanni Guaraldi,Massimo Girardis,(unknown),(unknown),Neubury M. Lardy,Mireille Toebes,Robert Balderas,Ton N. Schumacher,Huib Ovaa,Andrea Cossarizza,Pia Kvistborg	69
4	863 Identification and characterization of an immunodominant SARS-CoV-2-specific CD8 T cell response 2020 ·SHILAP Revista de lepidopterología ·Anastasia Gangaev,Pia Kvistborg	3
5	Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma 2018 ·Cancer Immunology Research ·Sabrina A. Hogan,Anaïs Courtier,Phil F. Cheng,(unknown),Simone M. Goldinger,Manuarii Manuel,Solène Perez,(unknown),(unknown),Thi Dan Linh Nguyen‐Kim,Marieke I.G. Raaijmakers,Pia Kvistborg,Nicolas Pasqual,John B.A.G. Haanen,Reinhard Dummer,Mitchell P. Levesque	100
6	Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option 2018 ·Journal for ImmunoTherapy of Cancer ·Maartje W. Rohaan,Joost H. van den Berg,Pia Kvistborg,John B.A.G. Haanen	139
7	(Neo-)adjuvant ipilimumab + nivolumab (IPI+NIVO) in palpable stage 3 melanoma – updated relapse free survival (RFS) data from the OpACIN trial and first biomarker analyses 2017 ·Annals of Oncology ·Elisa A. Rozeman,Lorenzo F. Fanchi,Alexander C. J. van Akkooi,Pia Kvistborg,(unknown),(unknown),Brian D. Lamon,J.B.A.G. Haanen,Ton N. Schumacher,Christian U. Blank	10
8	HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia 2017 ·Cancer Immunology Immunotherapy ·Sanne Samuels,A. Marijne Heeren,Henry Zijlmans,Marij J.P. Welters,Joost H. van den Berg,Daisy Philips,Pia Kvistborg,Ilina Ehsan,Suzy Scholl,Bastiaan Nuijen,Ton N. Schumacher,Marc van Beurden,Ekaterina S. Jordanova,John B.A.G. Haanen,Sjoerd H. van der Burg,Gemma G. Kenter	15
9	Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma 2016 ·Journal of Clinical Oncology ·Sofie Wilgenhof,Jurgen Corthals,Carlo Heirman,Nicolas van Baren,Sophie Lucas,Pia Kvistborg,Kris Thielemans,Bart Neyns	240
10	pMHC Multiplexing Strategy to Detect High Numbers of T Cell Responses in Parallel 2016 ·Methods in molecular biology ·Daisy Philips,Marlous van den Braber,Ton N. Schumacher,Pia Kvistborg	1
11	(Neo-)adjuvant ipilimumab + nivolumab (IPI + NIVO) in palpable stage 3 melanoma – initial data from the OpACIN trial 2016 ·Annals of Oncology ·(unknown),Alexander C. J. van Akkooi,Elisa A. Rozeman,Pia Kvistborg,(unknown),(unknown),Brian D. Lamon,John B.A.G. Haanen,Ton N. Schumacher	9
12	Novel technologies and emerging biomarkers for personalized cancer immunotherapy 2016 ·Journal for ImmunoTherapy of Cancer ·Jianda Yuan,Priti S. Hegde,Raphael Clynes,Periklis Foukas,Alexandre Harari,Thomas O. Kleen,Pia Kvistborg,Cristina Maccalli,Holden T. Maecker,David B. Page,Harlan Robins,Wenru Song,Edward C. Stack,Ena Wang,Theresa L. Whiteside,Yingdong Zhao,H. Zwierzina,Lisa H. Butterfield,Bernard A. Fox	162
13	Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy 2015 ·Cancer Cell ·Sander Kelderman,Ton N. Schumacher,Pia Kvistborg	64
14	Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 ⁺ T cell response 2014 ·Science Translational Medicine ·Pia Kvistborg,Daisy Philips,Sander Kelderman,Lois Hageman,Christian H. Ottensmeier,Deborah Joseph-Pietras,Marij J.P. Welters,Sjoerd van der Burg,Ellen Kapiteijn,Olivier Michielin,Emanuela Romano,Carsten Linnemann,Daniel E. Speiser,Christian U. Blank,John B.A.G. Haanen,Ton N. Schumacher	288
15	Toward next-generation cancer immunotherapy: 10th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23–25, 2012 2013 ·Cancer Immunology Immunotherapy ·(unknown),(unknown),Richard Rae,Pia Kvistborg,Cedrik M. Britten,Sine Reker Hadrup	1
16	The cancer antigenome 2012 ·The EMBO Journal ·Bianca Heemskerk,Pia Kvistborg,Ton N. Schumacher	187
17	Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers 2012 ·Nature Protocols ·Rikke Andersen,Pia Kvistborg,Thomas Mørch Frøsig,Natasja Wulff Pedersen,Rikke Lyngaa,Arne Bakker,Chengyi J. Shu,Per thor Straten,Ton N. Schumacher,Sine Reker Hadrup	82
18	Clinical Benefit of Allogeneic Melanoma Cell Lysate–Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients 2009 ·Clinical Cancer Research ·Han Chong Toh,Who-Whong Wang,Whay Kuang Chia,Pia Kvistborg,Li Sun,(unknown),Yee Peng Phoon,(unknown),Sze Huey Tan,Siew Wan Hee,Kian Fong Foo,(unknown),Wen Hsin Koo,Mai-Britt Zocca,Mogens H. Claësson	54
19	Fast generation of dendritic cells 2009 ·Cellular Immunology ·Pia Kvistborg,(unknown),Ayako Wakatsuki Pedersen,Mogens H. Claësson,Mai-Britt Zocca	32
20	Spontaneous Immunity against Bcl-xL in Cancer Patients 2005 ·The Journal of Immunology ·Mads Hald Andersen,Sine Reker,Pia Kvistborg,Jürgen C. Becker,Per thor Straten	33

About Pia Kvistborg

Pia Kvistborg is a scholar working on Immunology, Oncology and Infectious Diseases, having authored 50 papers that have together received 3.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (36 papers), Cancer Immunotherapy and Biomarkers (27 papers) and CAR-T cell therapy research (21 papers). The work is most often cited by research in Immunology (2.1k citations), Oncology (2.2k citations) and Cancer Research (249 citations). Pia Kvistborg has collaborated with scholars based in Netherlands, United States and Denmark. Frequent co-authors include Ton N. Schumacher, Wouter Scheper, John B.A.G. Haanen, Bianca Heemskerk, Daisy Philips, Sander Kelderman, Marit M. van Buuren, Mireille Toebes, Nienke van Rooij and Christian U. Blank. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact